NCT00595517View on ClinicalTrials.gov

Long Term Study to Investigate the Efficacy & Safety of D961H (Esomeprazole) for the Prevention of NSAIDs-induced Ulcer

PHASE3CompletedINTERVENTIONAL
Enrollment

395

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Gastric UlcerDuodenal UlcerRheumatoid ArthritisOsteoarthritisLumbago
Interventions
DRUG

Esomeprazole 20 mg

Esomeprazole 20 mg once daily

Trial Locations (3)

Unknown

Research Site, Ōita

Research Site, Saitama

Research Site, Tokyo

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY